亚临床甲状腺功能减退对2型糖尿病肾病的影响:Fremantle糖尿病研究II期
该纵向观察研究纳入725例基线及随访时无已知甲状腺功能异常的2型糖尿病患者,按甲状腺状态分为持续甲功正常、暂时性亚临床/临床甲减和持续性亚临床/临床甲减。平均随访4.3年后,持续性亚临床/临床甲减组尿白蛋白/肌酐比值(ACR)显著升高,而估算肾小球滤过率(eGFR)无显著变化。
要点
- 持续性亚临床/临床甲减与2型糖尿病患者尿白蛋白排泄增加相关。
- 各组随访期间eGFR均无显著变化。
- 该研究提示2型糖尿病患者可能需要评估甲状腺功能。
核心结论
- 持续性亚临床/临床甲减与新发白蛋白尿增加相关,甲功正常者未见此现象。
- 研究提示对全部2型糖尿病患者评估甲状腺功能可能是有指征的。
研究设计与样本
- 纵向观察研究,纳入社区2型糖尿病患者725例,基线及随访时均无已知甲状腺功能异常。
- 按基线与随访甲状腺状态分为甲功正常、暂时性亚临床/临床甲减和持续性亚临床/临床甲减。
- 平均随访4.3±0.4年。
主要发现
- 随访结束时683例甲功稳定正常,18例暂时性亚临床/临床甲减,24例持续性亚临床/临床甲减。
- 各组eGFR均无显著变化。
- 持续性亚临床/临床甲减组ACR显著升高(ΔACR 22.0±81.4 mg/mmol),甲功正常组为0.4±36.7 mg/mmol,暂时性组为-0.3±5.7 mg/mmol,P=.027。
- 排除基线ACR>30 mg/mmol者后结果相似。
关键数值与推荐
- 持续性亚临床/临床甲减组ΔACR为22.0±81.4 mg/mmol,甲功正常组为0.4±36.7 mg/mmol,暂时性组为-0.3±5.7 mg/mmol,P=.027。
- 排除基线ACR>30 mg/mmol者后结果相似。
临床怎么用
- 对2型糖尿病患者考虑评估甲状腺功能,以识别持续性亚临床/临床甲减者。
- 对合并持续性亚临床/临床甲减的2型糖尿病患者关注尿白蛋白变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: It is uncertain whether subclinical hypothyroidism (SCH) contributes to intrinsic renal dysfunction in people with type 2 diabetes mellitus (T2DM). OBJECTIVE: To investigate whether SCH persisting over 4 years is associated with incident impairment of renal function in people with T2DM. DESIGN: Longitudinal observational study. SETTING: Urban population of people with type 2 diabetes living in the community and enrolled in a prospective observational study of diabetes. PARTICIPANTS: 725 without known thyroid dysfunction at baseline and at follow-up. MAIN OUTCOME MEASURES: Changes in estimated glomerular filtration rate (eGFR) and urine albumin:creatinine ratio (ACR) in participants stratified by thyroid status at baseline and follow-up into those with euthyroidism or transient or persistent subclinical (SCH)/overt hypothyroidism. RESULTS: After a mean ± SD 4.3 ± 0.4 years, 683 participants had stable euthyroidism, 18 transient SCH/overt hypothyroidism, and 24 persistent SCH/overt hypothyroidism. No significant changes in eGFR were observed in any group. Those with persistent SCH/overt hypothyroidism demonstrated a significant increase in ACR, which was not seen in those with euthyroidism and transient SCH/overt hypothyroidism (ΔACR 22.0 ± 81.4 vs 0.4 ± 36.7 and -0.3 ± 5.7 mg/mmol, respectively, P = .027). Similar results were seen when those with baseline ACR > 30 mg/mmol were excluded. CONCLUSION: Persistent SCH/overt hypothyroidism was associated with incident increased albuminuria not observed in euthyroid participants. Assessment of thyroid function in all patients with T2DM may be indicated, as some previous studies provide evidence that thyroxine replacement may ameliorate albuminuria.
引用
- Chubb SAP, Davis WA, Davis TME, et al. Effects of Subclinical Hypothyroidism on Nephropathy Complicating Type 2 Diabetes: The Fremantle Diabetes Study Phase II. J Clin Endocrinol Metab. 2026. PMID: 40878912. doi:10.1210/clinem/dgaf485
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。